drugset / Trial / NCT01889914

TReatment by Insulin Continuous Infusion in Type 2 DIAbetes

NCT01889914

Phase 4 Unknown 60 enrolled Centre Hospitalier Universitaire Dijon
RandomizedParallel-groupOpen-labelSupportive care

Summary

The aim of the TRICIDIA2 study is to compare two modalities of administration of insulin. In our future study, the investigators wish to study if the treatment by continuous infusion of insulin improves the insulinosensitivity of type 2 diabetic patients; the investigators indeed expect that the insulin delivered in a continuous way decreases the insulino-resistance of these patients compared with the intermittent delivering of insulin.

Timeline

Start
2012-01
Primary completion
2015-03
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin glulisine Protein / enzyme biologic Subcutaneous
Subject insulin detemir Protein / enzyme biologic